We are live on
!
Find out more
BCM
Beddow Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
18.36%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+18.36%
3 Year Est. Return
+50.71%
5 Year Est. Return
+107.72%
10 Year Est. Return
+272.89%
AUM
$161M
AUM Growth
+$2.1M
(+1.3%)
Cap. Flow
-$9.71M
Cap. Flow
% of AUM
-6.04%
Top 10 Holdings %
Top 10 Hldgs %
47.31%
Holding
51
New
5
Increased
15
Reduced
22
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$984K |
| 2 |
Franco-Nevada
FNV
|
+$973K |
| 3 |
1-800-Flowers.com
FLWS
|
+$487K |
| 4 |
BP
BP
|
+$291K |
| 5 |
Texas Pacific Land
TPL
|
+$240K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Timken Company
TKR
|
+$5.45M |
| 2 |
Liberty Global Class A
LBTYA
|
+$1.71M |
| 3 |
Baidu
BIDU
|
+$854K |
| 4 |
Merck
MRK
|
+$652K |
| 5 |
XEC
CIMAREX ENERGY CO
XEC
|
+$570K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.55% |
| 2 | Consumer Discretionary | 14.02% |
| 3 | Energy | 11.16% |
| 4 | Financials | 9.99% |
| 5 | Technology | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSB
1
Mesabi Trust
MSB
$320M
| $10.6M | 6.59% |
450,175
+238
| +0.1% | +$5.52K |
|
|
2
Texas Pacific Land
TPL
$28.7B
| $8.62M | 5.36% |
99,315
+3,285
| +3% | +$240K |
|
3
IBM
IBM
$200B
| $7.55M | 4.7% |
58,956
-99
| -0.2% | -$12.9K |
|
|
4
Johnson & Johnson
JNJ
$609B
| $7.38M | 4.59% |
50,560
+7,258
| +17% | +$984K |
|
5
Bladex Inc
BLX
$2.22B
| $7.12M | 4.43% |
332,967
+225
| +0.1% | +$4.75K |
|
|
ABB
6
DELISTED
ABB Ltd
ABB
| $6.83M | 4.25% |
283,520
-8,200
| -3% | -$176K |
|
7
AB InBev
BUD
$156B
| $6.32M | 3.93% |
76,995
+840
| +1% | +$70K |
|
8
Wynn Resorts
WYNN
$10B
| $5.74M | 3.57% |
41,365
-3,475
| -8% | -$423K |
|
9
Philips
PHG
$26.2B
| $5.57M | 3.47% |
143,681
-4,394
| -3% | -$159K |
|
10
Autoliv
ALV
$9B
| $5.45M | 3.39% |
64,541
-2,860
| -4% | -$234K |
|
11
Pfizer
PFE
$143B
| $5.4M | 3.36% |
145,244
+303
| +0.2% | +$10.8K |
|
12
Helmerich & Payne
HP
$3.41B
| $5.05M | 3.14% |
111,173
-4,992
| -4% | -$200K |
|
13
Berkshire Hathaway Class B
BRK.B
$1.06T
| $4.96M | 3.09% |
21,902
-1,180
| -5% | -$256K |
|
14
Wabtec
WAB
$44.5B
| $4.95M | 3.08% |
63,670
-1,475
| -2% | -$109K |
|
|
SI
15
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $4.68M | 2.91% |
72,007
-1,350
| -2% | -$87.7K |
|
16
Escalade
ESCA
$266M
| $4.02M | 2.5% |
408,701
-32,270
| -7% | -$350K |
|
|
17
1-800-Flowers.com
FLWS
$263M
| $4.01M | 2.49% |
276,532
+35,836
| +15% | +$487K |
|
|
18
Berkshire Hathaway Class A
BRK.A
$1.06T
| $3.73M | 2.32% |
11
| – | – |
|
19
AbbVie
ABBV
$450B
| $3.56M | 2.21% |
40,175
+1,013
| +3% | +$84.1K |
|
|
XEC
20
DELISTED
CIMAREX ENERGY CO
XEC
| $3.51M | 2.18% |
66,791
-12,257
| -16% | -$570K |
|
|
21
Merck
MRK
$315B
| $3.44M | 2.14% |
39,700
-7,935
| -17% | -$652K |
|
|
22
Franco-Nevada
FNV
$38.7B
| $3.31M | 2.06% |
31,995
+10,070
| +46% | +$973K |
|
|
23
Liberty Global Class A
LBTYA
$3.52B
| $3.3M | 2.05% |
145,300
-72,630
| -33% | -$1.71M |
|
|
CLR
24
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $3.17M | 1.97% |
92,267
-8,025
| -8% | -$249K |
|
25
Bristol-Myers Squibb
BMY
$124B
| $2.56M | 1.59% |
39,880
+1,710
| +4% | +$97.9K |
|
Similar funds
MCP
FCIS
SCM
GFA
RA
OI
GFG
EFA
Beddow Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Beddow Capital Management held 51 positions worth $161M, up 1.3% from $159M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Beddow Capital Management withdrew a net $9.71M in Q4 2019, closing 2 positions and reducing 22 holdings. Its most notable exit was Celgene Corp, an estimated $351K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Energy.
Against the trend, Beddow Capital Management opened a new position in BP worth $290K.
- Beddow Capital Management's largest Q4 2019 buy was BP: 7,675 shares worth $290K.
- Beddow Capital Management added most to Johnson & Johnson in Q4 2019, an estimated $984K increase.
- Beddow Capital Management's biggest Q4 2019 reduction was Timken Company, cutting an estimated $5.45M.
- Beddow Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $351K.
- Beddow Capital Management's ten largest holdings make up 47% of its $161M portfolio in Q4 2019.
- Beddow Capital Management opened 5 new positions and closed 2 in Q4 2019.
- Beddow Capital Management's portfolio value rose 1.3% quarter-over-quarter to $161M.
Based on Beddow Capital Management's 13F filing for Q4 2019, filed 5 Feb 2020.